Does Magnesium Help Blood Sugar? A New 247-Person Trial Complicates the Answer
A 247-person, 12-month trial of magnesium oxide missed its HbA1c target. Why weak evidence still leaves room to try it, if your kidneys are healthy.
Image by Showmeyourflowers via Pixabay
Does Magnesium Help Blood Sugar? A New 247-Person Trial Complicates the Answer
If your magnesium level is already normal, probably not much. That's the short answer from the largest and longest trial run on the question. Researchers in Oman gave 247 adults with type 2 diabetes magnesium oxide or a matching placebo daily for a year, then looked at HbA1c, the blood test that estimates your average blood sugar over about three months. Magnesium brought it down 0.30 percent against 0.05 percent on placebo, and statistically those two numbers couldn't be told apart.
A thin result is not the same as a reason to skip it, though, and I want to be clear about that before we go further. Magnesium is inexpensive, it's well tolerated by most people, and it has one clear contraindication rather than a long list. If your kidneys are healthy, trying it is a small bet with a small downside. What the evidence should shape is how much you expect from it.
The headlines coming out of this study will say magnesium doesn't work for blood sugar. None of them will mention which form of magnesium was used, nor how many people in the trial were low to begin with. What happened inside the trial turns on exactly those two questions: what form, and what status.
What the trial actually found
The design was good: double-blind, placebo-controlled, and twelve months long, which is unusual for a supplement study. Everyone enrolled had an HbA1c at or above 7 percent, so there was room to come down, and median diabetes duration was sixteen years.
Fasting blood glucose did come down significantly, though only in one subgroup analysis that the paper's summary doesn't spell out. And more people in the magnesium arm got their HbA1c under 7 percent: 14 percent of them, against 6 percent on placebo. That figure is a secondary result on a trial that missed its main one, which makes it a lead to follow rather than a finding to act on.
The form question
They used magnesium oxide. I've made more videos about magnesium forms than about almost anything else, because the word "magnesium" on a label tells you very little about how much of it gets into you.
Magnesium oxide is cheap and it's everywhere. It carries a lot of elemental magnesium per capsule, which reads well on a label. What it does poorly is absorb. In the one published comparison of US commercial preparations, oxide came in at roughly 4 percent fractional absorption, well behind magnesium chloride, lactate and aspartate. The laxative effect people notice is the clue: a share of what you swallow stays in your gut and pulls water in behind it instead of crossing into your blood. Citrate and the amino-acid-bound forms like glycinate are generally considered better absorbed, though the head-to-head trials putting them against each other are thin.
So a trial built on magnesium oxide is a trial of one of the poorest-absorbed forms on the shelf. A weak signal from that design tells you a fair amount about magnesium oxide. It tells you less about magnesium. Which form suits a particular person is a conversation for them and their own provider.
The status question
Now the second question, which does more work than the first. Of the 247 people in this trial, roughly one in twelve was actually low in magnesium at the start, 7.3 percent by ionized magnesium and 8.1 percent by total. So for about ninety-two out of every hundred participants, the study was asking what happens when you give magnesium to someone who already has enough. Repleting a deficiency and topping up a person who isn't deficient are two different interventions, and most magnesium advice online collapses that distinction entirely.
The subgroup analysis is where you can see it. Among participants who started out low, HbA1c fell 0.60 percent while the placebo group's rose 0.25 percent, twice the drop seen in the magnesium arm overall. It still didn't reach significance, and with fewer than twenty-five people carrying that subgroup, it was never going to.
Where the rest of the evidence sits
This trial didn't overturn anything. It fits a body of research that has said roughly the same thing for twenty years, with disagreement at the edges.
A 2006 meta-analysis of nine double-blind trials covering 370 people found fasting glucose came down significantly while HbA1c didn't. A 2025 meta-analysis of 23 trials found the same split, with the HbA1c confidence interval running right up against zero. Pointing the other way, a 2023 pooled analysis of 24 trials did find a significant HbA1c reduction of 0.22 percent. Small, and statistically there.
The deficiency question splits the same way. A 2003 trial gave magnesium chloride to 63 people who all had low serum magnesium, and both insulin sensitivity and HbA1c improved. Against that, a Dutch study recruited people with low magnesium and used a hyperinsulinemic-euglycemic clamp, the gold standard: infuse insulin and glucose at controlled rates, then watch how much glucose the body takes up. Nothing improved, though only 14 people enrolled.
Add it up and the pattern is consistent enough to state plainly. Fasting glucose moves. HbA1c moves a little, inconsistently, and mostly in people who were low to begin with. Anyone telling you magnesium lowers your A1c is running ahead of what twenty years of trials support. Anyone telling you magnesium is useless for blood sugar is overstating in the other direction.
Status before supplement
Most people who arrive in my office with magnesium already in the cabinet have never had a magnesium level checked. The bottle is usually oxide, usually from a big-box store, usually bought because someone online mentioned sleep or cramps or blood sugar. Nobody ever measured whether they were short on it to begin with.
The order I'd rather see is status before supplement: find out whether the nutrient is actually low, then decide whether replacing it should be expected to do anything. When someone is low, correcting that is reasonable for its own sake, and this trial's deficiency subgroup hints blood sugar may improve alongside it. When someone isn't low, twelve months of magnesium oxide bought a quarter of a percentage point of HbA1c that the statistics couldn't tell apart from chance.
That order governs your expectations, not your permission to try anything. Weak evidence and high risk are two different problems, and magnesium only has the first one. In this trial the magnesium group reported no more adverse reactions than the placebo group, and the practical cost of being wrong is a few dollars and, with the poorly absorbed forms, some loose stools. Given a downside that small, waiting on a lab result you may struggle to get isn't the call I'd make for most people.
The line I do hold is kidney function. That trial excluded anyone whose creatinine clearance sat at or below 30 mL/min, the marker for significantly reduced kidney function, and that exclusion is there for a reason: your kidneys are how you clear magnesium you don't need. When kidney function is reduced, the safety picture changes entirely, and that conversation belongs with your nephrologist or prescribing doctor rather than with a blog post. If you don't know what your kidney function is, that's the thing to find out first.
And none of this is a reason to change what you're taking for your blood sugar. Magnesium was studied as an addition to standard care, which is the only context these results speak to.
I've written before about the gut microbiome's role in insulin resistance, and about what beets and leafy greens do for the cognitive side of type 2 diabetes. Those greens are also among the better food sources of magnesium.
So where does that leave you? If your kidneys are healthy, a trial of magnesium is one of the lower-stakes things you could add, and a better-absorbed form is the sensible starting point, seeing as oxide is the one that performed poorly in the absorption work. The realistic expectation is a small effect, or none. A magnesium level, if you can get one, still tells you something the bottle can't: whether you were low to begin with.
Everything here is education rather than medical advice for your situation. Your labs, your kidneys, and your medication list decide what's appropriate, and your own clinician is the one who can see all three at once.
If you want a structured way through metabolic health rather than reading posts one at a time, the Wayfinder's Well membership is where the full course library lives, and the diabetes course is being built there now.
FAQ
Does magnesium lower HbA1c in type 2 diabetes?
Not reliably, and not much. The largest and longest trial to date gave 247 adults magnesium oxide or placebo for 12 months and found HbA1c fell 0.30 percent on magnesium versus 0.05 percent on placebo, a difference the statistics couldn't separate from chance. Meta-analyses disagree at the edges: a 2023 pooled analysis of 24 trials found a significant reduction of about 0.22 percent, while a 2025 analysis of 23 trials found the effect minimal. Fasting glucose is the measure that moves more consistently.
How do I know if I am low in magnesium?
A blood test is the starting point, and it's an imperfect one. Most of the body's magnesium sits inside cells and bone rather than in the bloodstream, so a normal serum level doesn't completely rule out a shortfall. The 2026 trial measured participants two ways and got two different deficiency rates, 7.3 percent by ionized magnesium and 8.1 percent by total magnesium. Ask your own clinician whether testing makes sense for your situation and which measure they use.
Why does the form of magnesium matter?
Different magnesium compounds are absorbed to very different degrees. In the one published comparison of US commercial preparations, magnesium oxide showed fractional absorption of about 4 percent, well below magnesium chloride, lactate and aspartate, which performed similarly to each other. The laxative effect many people notice from oxide is a sign that a share of it stays in the gut. Citrate and the amino-acid-bound forms such as glycinate are generally considered better absorbed, though head-to-head trials between them are thin. Which one suits a person depends on tolerance, cost and purpose, so that choice belongs in a conversation with your own provider.
Is magnesium safe to take alongside diabetes medication?
In this trial magnesium was added on top of standard diabetes care and no difference in adverse reactions appeared between the magnesium and placebo groups. That is reassuring for the population studied, which excluded people with significantly reduced kidney function. Magnesium is cleared by the kidneys, so reduced kidney function changes the safety picture entirely. Tell your prescriber before adding anything, and never substitute a supplement for prescribed medication.
Should everyone with type 2 diabetes take magnesium?
Everyone is a strong word, and the trial evidence doesn't support a blanket yes. In the 2026 trial roughly one participant in twelve was actually low in magnesium at baseline, and the HbA1c signal was concentrated in that small subgroup rather than spread across everyone. Repleting a documented deficiency and topping up someone who already has enough are different interventions with different expected returns. That said, magnesium is inexpensive and was no harder on participants than placebo in that trial, so for someone with healthy kidneys a trial of it is a low-stakes thing to raise with their own clinician. Reduced kidney function changes that answer completely.
Can magnesium prevent or reverse type 2 diabetes?
Nothing in this trial speaks to it, and the claim runs ahead of what has been shown. The closest evidence is a 2015 Mexican trial in 116 adults who had both prediabetes and low magnesium: four months of magnesium chloride moved more of them back toward normal glucose than placebo did, about 51 percent against 7 percent. That is a result in a specific, deficient, pre-diabetic population over four months. It isn't the same as showing that magnesium prevents type 2 diabetes or reverses an established diagnosis, and no trial has measured either of those endpoints.
References
- 1.
- 2.
- 3.
- 4.
- 5.
- 6.
- 7.
- 8.
